A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas

doi:10.1084/jem.180.1.35

This Article

	Full Text (PDF, 764K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Coulie, P. G.
	Articles by Szikora, J. P.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Coulie, P. G.
	Articles by Szikora, J. P.


Social Bookmarking

	What's this?

ARTICLES

A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas

PG Coulie, V Brichard, A Van Pel, T Wolfel, J Schneider, C Traversari, S Mattei, E De Plaen, C Lurquin and JP Szikora
Ludwig Institute for Cancer Research, Brussels, Belgium.

It has been reported previously that antitumor cytolytic T lymphocyte (CTL) clones can be isolated from blood lymphocytes of HLA-A2 melanoma patients, after stimulation in vitro with autologous tumor cells, and that some of these CTL clones lyse most HLA-A2 melanomas. A first antigen recognized by such CTL clones was previously shown to be encoded by the tyrosinase gene. We report here the identification of another gene that also directs the expression of an antigen recognized on most melanomas by CTL clones that are restricted by HLA-A2. The gene, designated Melan-A, is unrelated to any known gene. It is 18 kb long and comprises five exons. Like the tyrosinase gene, it is expressed in most melanoma tumor samples and, among normal cells, only in melanocytes.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to Technorati Technorati What's this?

This article has been cited by other articles:

Godet, Y., Moreau-Aubry, A., Guilloux, Y., Vignard, V., Khammari, A., Dreno, B., Jotereau, F., Labarriere, N. (2008). MELOE-1 is a new antigen overexpressed in melanomas and involved in adoptive T cell transfer efficiency. JEM 205: 2673-2682 [Abstract] [Full Text]
Segal, N. H., Parsons, D. W., Peggs, K. S., Velculescu, V., Kinzler, K. W., Vogelstein, B., Allison, J. P. (2008). Epitope Landscape in Breast and Colorectal Cancer. Cancer Res. 68: 889-892 [Abstract] [Full Text]
Derre, L., Ferber, M., Touvrey, C., Devevre, E., Zoete, V., Leimgruber, A., Romero, P., Michielin, O., Levy, F., Speiser, D. E. (2007). A Novel Population of Human Melanoma-Specific CD8 T Cells Recognizes Melan-AMART-1 Immunodominant Nonapeptide but Not the Corresponding Decapeptide. J. Immunol. 179: 7635-7645 [Abstract] [Full Text]
Santegoets, S. J. A. M., Schreurs, M. W. J., Reurs, A. W., Lindenberg, J. J., Kueter, E. W. M., van den Eertwegh, A. J. M., Hooijberg, E., Brandwijk, R. J., Hufton, S. E., Hoogenboom, H. R., Scheper, R. J., Somers, V. A., de Gruijl, T. D. (2007). Identification and Characterization of ErbB-3-Binding Protein-1 as a Target for Immunotherapy. J. Immunol. 179: 2005-2012 [Abstract] [Full Text]
Sabbatini, P., Odunsi, K. (2007). Immunologic Approaches to Ovarian Cancer Treatment. JCO 25: 2884-2893 [Abstract] [Full Text]
Parmiani, G., De Filippo, A., Novellino, L., Castelli, C. (2007). Unique Human Tumor Antigens: Immunobiology and Use in Clinical Trials. J. Immunol. 178: 1975-1979 [Abstract] [Full Text]
Xu, H., Shan, J., Jurukovski, V., Yuan, L., Li, J., Tian, K. (2007). TSP50 Encodes a Testis-Specific Protease and Is Negatively Regulated by p53. Cancer Res. 67: 1239-1245 [Abstract] [Full Text]
Walton, S. M., Gerlinger, M., de la Rosa, O., Nuber, N., Knights, A., Gati, A., Laumer, M., Strauss, L., Exner, C., Schafer, N., Urosevic, M., Dummer, R., Tiercy, J.-M., Mackensen, A., Jaeger, E., Levy, F., Knuth, A., Jager, D., Zippelius, A. (2006). Spontaneous CD8 T Cell Responses against the Melanocyte Differentiation Antigen RAB38/NY-MEL-1 in Melanoma Patients. J. Immunol. 177: 8212-8218 [Abstract] [Full Text]
Bioley, G., Jandus, C., Tuyaerts, S., Rimoldi, D., Kwok, W. W., Speiser, D. E., Tiercy, J.-M., Thielemans, K., Cerottini, J.-C., Romero, P. (2006). Melan-A/MART-1-Specific CD4 T Cells in Melanoma Patients: Identification of New Epitopes and Ex Vivo Visualization of Specific T Cells by MHC Class II Tetramers. J. Immunol. 177: 6769-6779 [Abstract] [Full Text]
Mackensen, A., Meidenbauer, N., Vogl, S., Laumer, M., Berger, J., Andreesen, R. (2006). Phase I Study of Adoptive T-Cell Therapy Using Antigen-Specific CD8+ T Cells for the Treatment of Patients With Metastatic Melanoma. JCO 24: 5060-5069 [Abstract] [Full Text]
Hodi, F. S. (2006). Well-Defined Melanoma Antigens as Progression Markers for Melanoma: Insights into Differential Expression and Host Response Based on Stage. Clin. Cancer Res. 12: 673-678 [Full Text]
Baruah, P., Propato, A., Dumitriu, I. E., Rovere-Querini, P., Russo, V., Fontana, R., Accapezzato, D., Peri, G., Mantovani, A., Barnaba, V., Manfredi, A. A. (2006). The pattern recognition receptor PTX3 is recruited at the synapse between dying and dendritic cells, and edits the cross-presentation of self, viral, and tumor antigens. Blood 107: 151-158 [Abstract] [Full Text]
Berger, A. J., Davis, D. W., Tellez, C., Prieto, V. G., Gershenwald, J. E., Johnson, M. M., Rimm, D. L., Bar-Eli, M. (2005). Automated Quantitative Analysis of Activator Protein-2{alpha} Subcellular Expression in Melanoma Tissue Microarrays Correlates with Survival Prediction. Cancer Res. 65: 11185-11192 [Abstract] [Full Text]
Nishikawa, H., Kato, T., Tawara, I., Ikeda, H., Kuribayashi, K., Allen, P. M., Schreiber, R. D., Old, L. J., Shiku, H. (2005). IFN-{gamma} Controls the Generation/Activation of CD4+CD25+ Regulatory T Cells in Antitumor Immune Response. J. Immunol. 175: 4433-4440 [Abstract] [Full Text]
Vignard, V., Lemercier, B., Lim, A., Pandolfino, M.-C., Guilloux, Y., Khammari, A., Rabu, C., Echasserieau, K., Lang, F., Gougeon, M.-L., Dreno, B., Jotereau, F., Labarriere, N. (2005). Adoptive Transfer of Tumor-Reactive Melan-A-Specific CTL Clones in Melanoma Patients Is Followed by Increased Frequencies of Additional Melan-A-Specific T Cells. J. Immunol. 175: 4797-4805 [Abstract] [Full Text]
Nagata, Y., Hanagiri, T., Takenoyama, M., Fukuyama, T., Mizukami, M., So, T., Ichiki, Y., Sugaya, M., Sugio, K., Yasumoto, K. (2005). Identification of the HLA-Cw*0702-Restricted Tumor-Associated Antigen Recognized by a CTL Clone from a Lung Cancer Patient. Clin. Cancer Res. 11: 5265-5272 [Abstract] [Full Text]
Yamshchikov, G. V., Mullins, D. W., Chang, C.-C., Ogino, T., Thompson, L., Presley, J., Galavotti, H., Aquila, W., Deacon, D., Ross, W., Patterson, J. W., Engelhard, V. H., Ferrone, S., Slingluff, C. L. Jr (2005). Sequential Immune Escape and Shifting of T Cell Responses in a Long-Term Survivor of Melanoma. J. Immunol. 174: 6863-6871 [Abstract] [Full Text]
Hoashi, T., Watabe, H., Muller, J., Yamaguchi, Y., Vieira, W. D., Hearing, V. J. (2005). MART-1 Is Required for the Function of the Melanosomal Matrix Protein PMEL17/GP100 and the Maturation of Melanosomes. J. Biol. Chem. 280: 14006-14016 [Abstract] [Full Text]
Levy, F., Muehlethaler, K., Salvi, S., Peitrequin, A.-L., Lindholm, C. K., Cerottini, J.-C., Rimoldi, D. (2005). Ubiquitylation of a Melanosomal Protein by HECT-E3 Ligases Serves as Sorting Signal for Lysosomal Degradation. Mol. Biol. Cell 16: 1777-1787 [Abstract] [Full Text]
Germeau, C., Ma, W., Schiavetti, F., Lurquin, C., Henry, E., Vigneron, N., Brasseur, F., Lethe, B., De Plaen, E., Velu, T., Boon, T., Coulie, P. G. (2005). High frequency of antitumor T cells in the blood of melanoma patients before and after vaccination with tumor antigens. JEM 201: 241-248 [Abstract] [Full Text]
van Dinten, L. C., Pul, N., van Nieuwpoort, A. F., Out, C. J., Jager, M. J., van den Elsen, P. J. (2005). Uveal and Cutaneous Melanoma: Shared Expression Characteristics of Melanoma-Associated Antigens. IOVS 46: 24-30 [Abstract] [Full Text]
Mehrotra, S., Chhabra, A., Chattopadhyay, S., Dorsky, D. I., Chakraborty, N. G., Mukherji, B. (2004). Rescuing Melanoma Epitope-Specific Cytolytic T Lymphocytes from Activation-Induced Cell Death, by SP600125, an Inhibitor of JNK: Implications in Cancer Immunotherapy. J. Immunol. 173: 6017-6024 [Abstract] [Full Text]
Yoshitake, Y., Nakatsura, T., Monji, M., Senju, S., Matsuyoshi, H., Tsukamoto, H., Hosaka, S., Komori, H., Fukuma, D., Ikuta, Y., Katagiri, T., Furukawa, Y., Ito, H., Shinohara, M., Nakamura, Y., Nishimura, Y. (2004). Proliferation Potential-Related Protein, an Ideal Esophageal Cancer Antigen for Immunotherapy, Identified Using Complementary DNA Microarray Analysis. Clin. Cancer Res. 10: 6437-6448 [Abstract] [Full Text]
Wong, R., Lau, R., Chang, J., Kuus-Reichel, T., Brichard, V., Bruck, C., Weber, J. (2004). Immune Responses to a Class II Helper Peptide Epitope in Patients with Stage III/IV Resected Melanoma. Clin. Cancer Res. 10: 5004-5013 [Abstract] [Full Text]
Ayyoub, M., Hesdorffer, C. S., Metthez, G., Stevanovic, S., Ritter, G., Chen, Y.-T., Old, L. J., Speiser, D., Cerottini, J.-C., Valmori, D. (2004). Identification of an SSX-2 Epitope Presented by Dendritic Cells to Circulating Autologous CD4+ T Cells. J. Immunol. 172: 7206-7211 [Abstract] [Full Text]
Zippelius, A., Batard, P., Rubio-Godoy, V., Bioley, G., Lienard, D., Lejeune, F., Rimoldi, D., Guillaume, P., Meidenbauer, N., Mackensen, A., Rufer, N., Lubenow, N., Speiser, D., Cerottini, J.-C., Romero, P., Pittet, M. J. (2004). Effector Function of Human Tumor-Specific CD8 T Cells in Melanoma Lesions: A State of Local Functional Tolerance. Cancer Res. 64: 2865-2873 [Abstract] [Full Text]
Yamaguchi, H., Tanaka, F., Ohta, M., Inoue, H., Mori, M. (2004). Identification of HLA-A24-Restricted CTL Epitope from Cancer-Testis Antigen, NY-ESO-1, and Induction of a Specific Antitumor Immune Response. Clin. Cancer Res. 10: 890-896 [Abstract] [Full Text]
de Rijke, B., Fredrix, H., Zoetbrood, A., Scherpen, F., Witteveen, H., de Witte, T., van de Wiel-van Kemenade, E., Dolstra, H. (2003). Generation of autologous cytotoxic and helper T-cell responses against the B-cell leukemia-associated antigen HB-1: relevance for precursor B-ALL-specific immunotherapy. Blood 102: 2885-2891 [Abstract] [Full Text]
Rezvani, K., Grube, M., Brenchley, J. M., Sconocchia, G., Fujiwara, H., Price, D. A., Gostick, E., Yamada, K., Melenhorst, J., Childs, R., Hensel, N., Douek, D. C., Barrett, A. J. (2003). Functional leukemia-associated antigen-specific memory CD8+ T cells exist in healthy individuals and in patients with chronic myelogenous leukemia before and after stem cell transplantation. Blood 102: 2892-2900 [Abstract] [Full Text]
Odunsi, K., Jungbluth, A. A., Stockert, E., Qian, F., Gnjatic, S., Tammela, J., Intengan, M., Beck, A., Keitz, B., Santiago, D., Williamson, B., Scanlan, M. J., Ritter, G., Chen, Y.-T., Driscoll, D., Sood, A., Lele, S., Old, L. J. (2003). NY-ESO-1 and LAGE-1 Cancer-Testis Antigens Are Potential Targets for Immunotherapy in Epithelial Ovarian Cancer. Cancer Res. 63: 6076-6083 [Abstract] [Full Text]
Mehrotra, S., Stevens, R., Zengou, R., Chakraborty, N. G., Butterfield, L. H., Economou, J. S., Dorsky, D. I., Mukherji, B. (2003). Regulation of Melanoma Epitope-specific Cytolytic T Lymphocyte Response by Immature and Activated Dendritic Cells, in Vitro. Cancer Res. 63: 5607-5614 [Abstract] [Full Text]
Denkberg, G., Lev, A., Eisenbach, L., Benhar, I., Reiter, Y. (2003). Selective Targeting of Melanoma and APCs Using a Recombinant Antibody with TCR-Like Specificity Directed Toward a Melanoma Differentiation Antigen. J. Immunol. 171: 2197-2207 [Abstract] [Full Text]
Du, J., Miller, A. J., Widlund, H. R., Horstmann, M. A., Ramaswamy, S., Fisher, D. E. (2003). MLANA/MART1 and SILV/PMEL17/GP100 Are Transcriptionally Regulated by MITF in Melanocytes and Melanoma. Am. J. Pathol. 163: 333-343 [Abstract] [Full Text]
Peterson, A. C., Harlin, H., Gajewski, T. F. (2003). Immunization With Melan-A Peptide-Pulsed Peripheral Blood Mononuclear Cells Plus Recombinant Human Interleukin-12 Induces Clinical Activity and T-Cell Responses in Advanced Melanoma. JCO 21: 2342-2348 [Abstract] [Full Text]
Admon, A., Barnea, E., Ziv, T. (2003). Tumor Antigens and Proteomics from the Point of View of the Major Histocompatibility Complex Peptides. Mol. Cell. Proteomics 2: 388-398 [Abstract] [Full Text]
Dietrich, P.-Y., Le Gal, F.-A., Dutoit, V., Pittet, M. J., Trautman, L., Zippelius, A., Cognet, I., Widmer, V., Walker, P. R., Michielin, O., Guillaume, P., Connerotte, T., Jotereau, F., Coulie, P. G., Romero, P., Cerottini, J.-C., Bonneville, M., Valmori, D. (2003). Prevalent Role of TCR {alpha}-Chain in the Selection of the Preimmune Repertoire Specific for a Human Tumor-Associated Self-Antigen. J. Immunol. 170: 5103-5109 [Abstract] [Full Text]
Yaziji, H., Gown, A. M. (2003). Immunohistochemical Markers of Melanocytic Tumors. INT J SURG PATHOL 11: 11-15 [Abstract]
Yee, C., Thompson, J. A., Byrd, D., Riddell, S. R., Roche, P., Celis, E., Greenberg, P. D. (2002). Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: In vivo persistence, migration, and antitumor effect of transferred T cells. Proc. Natl. Acad. Sci. USA 99: 16168-16173 [Abstract] [Full Text]
Mantovani, S., Palermo, B., Garbelli, S., Campanelli, R., Robustelli della Cuna, G., Gennari, R., Benvenuto, F., Lantelme, E., Giachino, C. (2002). Dominant TCR-{alpha} Requirements for a Self Antigen Recognition in Humans. J. Immunol. 169: 6253-6260 [Abstract] [Full Text]
Rubio-Godoy, V., Dutoit, V., Zhao, Y., Simon, R., Guillaume, P., Houghten, R., Romero, P., Cerottini, J.-C., Pinilla, C., Valmori, D. (2002). Positional Scanning-Synthetic Peptide Library-Based Analysis of Self- and Pathogen-Derived Peptide Cross-Reactivity with Tumor-Reactive Melan-A-Specific CTL. J. Immunol. 169: 5696-5707 [Abstract] [Full Text]
Mandruzzato, S., Rossi, E., Bernardi, F., Tosello, V., Macino, B., Basso, G., Chiarion-Sileni, V., Rossi, C. R., Montesco, C., Zanovello, P. (2002). Large and Dissimilar Repertoire of Melan-A/MART-1-Specific CTL in Metastatic Lesions and Blood of a Melanoma Patient. J. Immunol. 169: 4017-4024 [Abstract] [Full Text]
Dutoit, V., Rubio-Godoy, V., Pittet, M. J., Zippelius, A., Dietrich, P.-Y., Legal, F. A., Guillaume, P., Romero, P., Cerottini, J.-C., Houghten, R. A., Pinilla, C., Valmori, D. (2002). Degeneracy of Antigen Recognition as the Molecular Basis for the High Frequency of Naive A2/Melan-A Peptide Multimer+ CD8+ T Cells in Humans. JEM 196: 207-216 [Abstract] [Full Text]
Denkberg, G., Cohen, C. J., Lev, A., Chames, P., Hoogenboom, H. R., Reiter, Y. (2002). Direct visualization of distinct T cell epitopes derived from a melanoma tumor-associated antigen by using human recombinant antibodies with MHC- restricted T cell receptor-like specificity. Proc. Natl. Acad. Sci. USA 99: 9421-9426 [Abstract] [Full Text]
Sugaya, M., Takenoyama, M., Osaki, T., Yasuda, M., Nagashima, A., Sugio, K., Yasumoto, K. (2002). Establishment of 15 Cancer Cell Lines From Patients With Lung Cancer and the Potential Tools for Immunotherapy*. Chest 122: 282-288 [Abstract] [Full Text]
Sosman, J. A., Unger, J. M., Liu, P.-Y., Flaherty, L. E., Park, M. S., Kempf, R. A., Thompson, J. A., Terasaki, P. I., Sondak, V. K. (2002). Adjuvant Immunotherapy of Resected, Intermediate-Thickness, Node-Negative Melanoma With an Allogeneic Tumor Vaccine: Impact of HLA Class I Antigen Expression on Outcome. JCO 20: 2067-2075 [Abstract] [Full Text]
Valmori, D., Dutoit, V., Schnuriger, V., Quiquerez, A.-L., Pittet, M. J., Guillaume, P., Rubio-Godoy, V., Walker, P. R., Rimoldi, D., Lienard, D., Cerottini, J.-C., Romero, P., Dietrich, P.-Y. (2002). Vaccination with a Melan-A Peptide Selects an Oligoclonal T Cell Population with Increased Functional Avidity and Tumor Reactivity. J. Immunol. 168: 4231-4240 [Abstract] [Full Text]
Rubio-Godoy, V., Pinilla, C., Dutoit, V., Borras, E., Simon, R., Zhao, Y., Cerottini, J.-C., Romero, P., Houghten, R., Valmori, D. (2002). Toward Synthetic Combinatorial Peptide Libraries in Positional Scanning Format (PS-SCL)-based Identification of CD8+ Tumor-reactive T-Cell Ligands: A Comparative Analysis of PS-SCL Recognition by a Single Tumor-reactive CD8+ Cytolytic T-Lymphocyte Clone. Cancer Res. 62: 2058-2063 [Abstract] [Full Text]
Jager, E., Salter, R., Castelli, C., Hohn, H., Freitag, K., Karbach, J., Neukirch, C., Necker, A., Knuth, A., Maeurer, M. J. (2002). Impact of Antigen Presentation on TCR Modulation and Cytokine Release: Implications for Detection and Sorting of Antigen-Specific CD8+ T Cells Using HLA-A2 Wild-Type or HLA-A2 Mutant Tetrameric Complexes. J. Immunol. 168: 2766-2772 [Abstract] [Full Text]
Zippelius, A., Pittet, M. J., Batard, P., Rufer, N., de Smedt, M., Guillaume, P., Ellefsen, K., Valmori, D., Lienard, D., Plum, J., MacDonald, H. R., Speiser, D. E., Cerottini, J.-C., Romero, P. (2002). Thymic Selection Generates a Large T Cell Pool Recognizing a Self-Peptide in Humans. JEM 195: 485-494 [Abstract] [Full Text]
Miconnet, I., Koenig, S., Speiser, D., Krieg, A., Guillaume, P., Cerottini, J.-C., Romero, P. (2002). CpG Are Efficient Adjuvants for Specific CTL Induction Against Tumor Antigen-Derived Peptide. J. Immunol. 168: 1212-1218 [Abstract] [Full Text]
Khong, H. T., Rosenberg, S. A. (2002). Pre-Existing Immunity to Tyrosinase-Related Protein (TRP)-2, a New TRP-2 Isoform, and the NY-ESO-1 Melanoma Antigen in a Patient with a Dramatic Response to Immunotherapy. J. Immunol. 168: 951-956 [Abstract] [Full Text]
Smith, S. G., Patel, P. M., Porte, J., Selby, P. J., Jackson, A. M. (2001). Human Dendritic Cells Genetically Engineered to Express a Melanoma Polyepitope DNA Vaccine Induce Multiple Cytotoxic T-Cell Responses. Clin. Cancer Res. 7: 4253-4261 [Abstract] [Full Text]
Rimoldi, D., Muehlethaler, K., Salvi, S., Valmori, D., Romero, P., Cerottini, J.-C., Levy, F. (2001). Subcellular Localization of the Melanoma-associated Protein Melan-AMART-1 Influences the Processing of Its HLA-A2-restricted Epitope. J. Biol. Chem. 276: 43189-43196 [Abstract] [Full Text]
Kao, H., Marto, J. A., Hoffmann, T. K., Shabanowitz, J., Finkelstein, S. D., Whiteside, T. L., Hunt, D. F., Finn, O. J. (2001). Identification of Cyclin B1 as a Shared Human Epithelial Tumor-Associated Antigen Recognized by T Cells. JEM 194: 1313-1324 [Abstract] [Full Text]
Armstrong, A C, Hawkins, R E (2001). Vaccines in oncology: background and clinical potential. Br. J. Radiol. 74: 991-1002 [Abstract] [Full Text]
Sliz, P., Michielin, O., Cerottini, J.-C., Luescher, I., Romero, P., Karplus, M., Wiley, D. C. (2001). Crystal Structures of Two Closely Related but Antigenically Distinct HLA-A2/Melanocyte-Melanoma Tumor-Antigen Peptide Complexes. J. Immunol. 167: 3276-3284 [Abstract] [Full Text]
Jager, D, Jager, E, Knuth, A (2001). Immune responses to tumour antigens: implications for antigen specific immunotherapy of cancer. J. Clin. Pathol. 54: 669-674 [Abstract] [Full Text]
Luft, T., Rizkalla, M., Tai, T. Y., Chen, Q., MacFarlan, R. I., Davis, I. D., Maraskovsky, E., Cebon, J. (2001). Exogenous Peptides Presented by Transporter Associated with Antigen Processing (TAP)-Deficient and TAP-Competent Cells: Intracellular Loading and Kinetics of Presentation. J. Immunol. 167: 2529-2537 [Abstract] [Full Text]
Dutoit, V., Rubio-Godoy, V., Dietrich, P.-Y., Quiqueres, A.-L., Schnuriger, V., Rimoldi, D., Lienard, D., Speiser, D., Guillaume, P., Batard, P., Cerottini, J.-C., Romero, P., Valmori, D. (2001). Heterogeneous T-Cell Response to MAGE-A10254-262: High Avidity-specific Cytolytic T Lymphocytes Show Superior Antitumor Activity. Cancer Res. 61: 5850-5856 [Abstract] [Full Text]
Salio, M., Shepherd, D., Dunbar, P. R., Palmowski, M., Murphy, K., Wu, L., Cerundolo, V. (2001). Mature Dendritic Cells Prime Functionally Superior Melan-A-Specific CD8+ Lymphocytes as Compared with Nonprofessional APC. J. Immunol. 167: 1188-1197 [Abstract] [Full Text]
Pinilla, C., Rubio-Godoy, V., Dutoit, V., Guillaume, P., Simon, R., Zhao, Y., Houghten, R. A., Cerottini, J.-C., Romero, P., Valmori, D. (2001). Combinatorial Peptide Libraries as an Alternative Approach to the Identification of Ligands for Tumor-reactive Cytolytic T Lymphocytes. Cancer Res. 61: 5153-5160 [Abstract] [Full Text]
Kurashige, T., Noguchi, Y., Saika, T., Ono, T., Nagata, Y., Jungbluth, A., Ritter, G., Chen, Y.-T., Stockert, E., Tsushima, T., Kumon, H., Old, L. J., Nakayama, E. (2001). NY-ESO-1 Expression and Immunogenicity Associated with Transitional Cell Carcinoma: Correlation with Tumor Grade. Cancer Res. 61: 4671-4674 [Abstract] [Full Text]
Miconnet, I., Coste, I., Beermann, F., Haeuw, J.-F., Cerottini, J.-C., Bonnefoy, J.-Y., Romero, P., Renno, T. (2001). Cancer Vaccine Design: A Novel Bacterial Adjuvant for Peptide-Specific CTL Induction. J. Immunol. 166: 4612-4619 [Abstract] [Full Text]
Ono, T., Kurashige, T., Harada, N., Noguchi, Y., Saika, T., Niikawa, N., Aoe, M., Nakamura, S., Higashi, T., Hiraki, A., Wada, H., Kumon, H., Old, L. J., Nakayama, E. (2001). Identification of proacrosin binding protein sp32 precursor as a human cancer/testis antigen. Proc. Natl. Acad. Sci. USA 98: 3282-3287 [Abstract] [Full Text]
Dietrich, P.-Y., Walker, P. R., Quiquerez, A.-L., Perrin, G., Dutoit, V., Liénard, D., Guillaume, P., Cerottini, J.-C., Romero, P., Valmori, D. (2001). Melanoma Patients Respond to a Cytotoxic T Lymphocyte-defined Self-Peptide with Diverse and Nonoverlapping T-Cell Receptor Repertoires. Cancer Res. 61: 2047-2054 [Abstract] [Full Text]
Jäger, D., Stockert, E., Güre, A. O., Scanlan, M. J., Karbach, J., Jäger, E., Knuth, A., Old, L. J., Chen, Y.-T. (2001). Identification of a Tissue-specific Putative Transcription Factor in Breast Tissue by Serological Screening of a Breast Cancer Library. Cancer Res. 61: 2055-2061 [Abstract] [Full Text]
Frost, P. J., Butterfield, L. H., Dissette, V. B., Economou, J. S., Bonavida, B. (2001). Immunosensitization of Melanoma Tumor Cells to Non-MHC Fas-Mediated Killing by MART-1-Specific CTL Cultures. J. Immunol. 166: 3564-3573 [Abstract] [Full Text]
Kessler, J. H., Beekman, N. J., Bres-Vloemans, S. A., Verdijk, P., van Veelen, P. A., Kloosterman-Joosten, A. M., Vissers, D. C.J., ten Bosch, G. J.A., Kester, M. G.D., Sijts, A., Drijfhout, J. W., Ossendorp, F., Offringa, R., Melief, C. J.M. (2001). Efficient Identification of Novel HLA-A*0201-presented Cytotoxic T Lymphocyte Epitopes in the Widely Expressed Tumor Antigen PRAME by Proteasome-mediated Digestion Analysis. JEM 193: 73-88 [Abstract] [Full Text]
Nishiyama, T., Tachibana, M., Horiguchi, Y., Nakamura, K., Ikeda, Y., Takesako, K., Murai, M. (2001). Immunotherapy of Bladder Cancer Using Autologous Dendritic Cells Pulsed with Human Lymphocyte Antigen-A24-specific MAGE-3 Peptide. Clin. Cancer Res. 7: 23-31 [Abstract] [Full Text]
Sorensen, B. S., Schmidt, H., von der Maase, H., Straten, P. T., Nexo, E. (2000). Quantification of Melanoma Cell-specific MART-1 mRNA in Peripheral Blood by a Calibrated Competitive Reverse Transcription-PCR. Clin. Chem. 46: 1923-1928 [Abstract] [Full Text]
Dunbar, P. R., Smith, C. L., Chao, D., Salio, M., Shepherd, D., Mirza, F., Lipp, M., Lanzavecchia, A., Sallusto, F., Evans, A., Russell-Jones, R., Harris, A. L., Cerundolo, V. (2000). A Shift in the Phenotype of Melan-A-Specific CTL Identifies Melanoma Patients with an Active Tumor-Specific Immune Response. J. Immunol. 165: 6644-6652 [Abstract] [Full Text]
Ramos-Vara, J. A., Beissenherz, M. E., Miller, M. A., Johnson, G. C., Pace, L. W., Fard, A., Kottler, S. J. (2000). Retrospective Study of 338 Canine Oral Melanomas with Clinical, Histologic, and Immunohistochemical Review of 129 Cases. Vet Pathol 37: 597-608 [Abstract] [Full Text]
Shaif-Muthana, M., McIntyre, C., Sisley, K., Rennie, I., Murray, A. (2000). Dead or Alive: Immunogenicity of Human Melanoma Cells When Presented by Dendritic Cells. Cancer Res. 60: 6441-6447 [Abstract] [Full Text]
Chaudhuri, S., Cariappa, A., Tang, M., Bell, D., Haber, D. A., Isselbacher, K. J., Finkelstein, D., Forcione, D., Pillai, S. (2000). Genetic susceptibility to breast cancer: HLA DQB*03032 and HLA DRB1*11 may represent protective alleles. Proc. Natl. Acad. Sci. USA 97: 11451-11454 [Abstract] [Full Text]
Jäger, E., Gnjatic, S., Nagata, Y., Stockert, E., Jäger, D., Karbach, J., Neumann, A., Rieckenberg, J., Chen, Y.-T., Ritter, G., Hoffman, E., Arand, M., Old, L. J., Knuth, A. (2000). Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers. Proc. Natl. Acad. Sci. USA 10.1073/pnas.220413497v1 [Abstract] [Full Text]
Gnjatic, S., Nagata, Y., Jager, E., Stockert, E., Shankara, S., Roberts, B. L., Mazzara, G. P., Lee, S. Y., Dunbar, P. R., Dupont, B., Cerundolo, V., Ritter, G., Chen, Y.-T., Knuth, A., Old, L. J. (2000). Strategy for monitoring T cell responses to NY-ESO-1 in patients with any HLA class I allele. Proc. Natl. Acad. Sci. USA 97: 10917-10922 [Abstract] [Full Text]
Kobayashi, H., Wood, M., Song, Y., Appella, E., Celis, E. (2000). Defining Promiscuous MHC Class II Helper T-Cell Epitopes for the HER2/neu Tumor Antigen. Cancer Res. 60: 5228-5236 [Abstract] [Full Text]
Kammula, U. S., Marincola, F. M., Rosenberg, S. A. (2000). Real-Time Quantitative Polymerase Chain Reaction Assessment of Immune Reactivity in Melanoma Patients After Tumor Peptide Vaccination. JNCI J Natl Cancer Inst 92: 1336-1344 [Abstract] [Full Text]
Jäger, D., Stockert, E., Jäger, E., Güre, A. O., Scanlan, M. J., Knuth, A., Old, L. J., Chen, Y.-T. (2000). Serological Cloning of a Melanocyte rab Guanosine 5'-Triphosphate-binding Protein and a Chromosome Condensation Protein from a Melanoma Complementary DNA Library. Cancer Res. 60: 3584-3591 [Abstract] [Full Text]
Martelange, V., De Smet, C., De Plaen, E., Lurquin, C., Boon, T. (2000). Identification on a Human Sarcoma of Two New Genes with Tumor-specific Expression. Cancer Res. 60: 3848-3855 [Abstract] [Full Text]
Robinson, C., Callow, M., Stevenson, S., Scott, B., Robinson, B. W. S., Lake, R. A. (2000). Serologic Responses in Patients with Malignant Mesothelioma . Evidence for Both Public and Private Specificities. Am. J. Respir. Cell Mol. Bio. 22: 550-556 [Abstract] [Full Text]
Oelke, M., Moehrle, U., Chen, J.-L., Behringer, D., Cerundolo, V., Lindemann, A., Mackensen, A. (2000). Generation and Purification of CD8+ Melan-A-specific Cytotoxic T Lymphocytes for Adoptive Transfer in Tumor Immunotherapy. Clin. Cancer Res. 6: 1997-2005 [Abstract] [Full Text]
Jager, E., Nagata, Y., Gnjatic, S., Wada, H., Stockert, E., Karbach, J., Dunbar, P. R., Lee, S. Y., Jungbluth, A., Jager, D., Arand, M., Ritter, G., Cerundolo, V., Dupont, B., Chen, Y.-T., Old, L. J., Knuth, A. (2000). Monitoring CD8 T cell responses to NY-ESO-1: Correlation of humoral and cellular immune responses. Proc. Natl. Acad. Sci. USA 97: 4760-4765 [Abstract] [Full Text]
Panelli, M. C., Bettinotti, M. P., Lally, K., Ohnmacht, G. A., Li, Y., Robbins, P., Riker, A., Rosenberg, S. A., Marincola, F. M. (2000). A Tumor-Infiltrating Lymphocyte from a Melanoma Metastasis with Decreased Expression of Melanoma Differentiation Antigens Recognizes MAGE-12. J. Immunol. 164: 4382-4392 [Abstract] [Full Text]
Disis, M. L., Schiffman, K., Gooley, T. A., McNeel, D. G., Rinn, K., Knutson, K. L. (2000). Delayed-Type Hypersensitivity Response Is a Predictor of Peripheral Blood T-Cell Immunity after HER-2/neu Peptide Immunization. Clin. Cancer Res. 6: 1347-1350 [Abstract] [Full Text]
Stewart, C J R, Nandini, C L, Richmond, J A (2000). Value of A103 (melan-A) immunostaining in the differential diagnosis of ovarian sex cord stromal tumours. J. Clin. Pathol. 53: 206-211 [Abstract] [Full Text]
Vogt, M. H. J., de Paus, R. A., Voogt, P. J., Willemze, R., Falkenburg, J. H. F. (2000). DFFRY codes for a new human male-specific minor transplantation antigen involved in bone marrow graft rejection. Blood 95: 1100-1105 [Abstract] [Full Text]
Zarour, H. M., Kirkwood, J. M., Kierstead, L. S., Herr, W., Brusic, V., Slingluff, C. L. Jr., Sidney, J., Sette, A., Storkus, W. J. (2000). Melan-A/MART-151-73 represents an immunogenic HLA-DR4-restricted epitope recognized by melanoma-reactive CD4+ T cells. Proc. Natl. Acad. Sci. USA 97: 400-405 [Abstract] [Full Text]
Valmori, D., Fonteneau, J.-F., Valitutti, S., Gervois, N., Dunbar, R., Lienard, D., Rimoldi, D., Cerundolo, V., Jotereau, F., Cerottini, J.-C., Speiser, D. E., Romero, P. (1999). Optimal activation of tumor-reactive T cells by selected antigenic peptide analogues. Int Immunol 11: 1971-1980 [Abstract] [Full Text]
Chiari, R., Foury, F., De Plaen, E., Baurain, J.-F., Thonnard, J., G. Coulie, P. (1999). Two Antigens Recognized by Autologous Cytolytic T Lymphocytes on a Melanoma Result from a Single Point Mutation in an Essential Housekeeping Gene. Cancer Res. 59: 5785-5792 [Abstract] [Full Text]
Mateo, L., Gardner, J., Chen, Q., Schmidt, C., Down, M., Elliott, S. L., Pye, S. J., Firat, H., Lemonnier, F. A., Cebon, J., Suhrbier, A. (1999). An HLA-A2 Polyepitope Vaccine for Melanoma Immunotherapy. J. Immunol. 163: 4058-4063 [Abstract] [Full Text]
Wang, F., Bade, E., Kuniyoshi, C., Spears, L., Jeffery, G., Marty, V., Groshen, S., Weber, J. (1999). Phase I Trial of a MART-1 Peptide Vaccine with Incomplete Freund's Adjuvant for Resected High-Risk Melanoma. Clin. Cancer Res. 5: 2756-2765 [Abstract] [Full Text]
Speiser, D. E., Pittet, M. J., Valmori, D., Dunbar, R., Rimoldi, D., Lienard, D., MacDonald, H. R., Cerottini, J.-C., Cerundolo, V., Romero, P. (1999). In Vivo Expression of Natural Killer Cell Inhibitory Receptors by Human Melanoma�specific Cytolytic T Lymphocytes. JEM 190: 775-782 [Abstract] [Full Text]
Pittet, M. J., Valmori, D., Dunbar, P. R., Speiser, D. E., Lienard, D., Lejeune, F., Fleischhauer, K., Cerundolo, V., Cerottini, J.-C., Romero, P. (1999). High Frequencies of Naive Melan-A/MART-1�specific CD8+ T Cells in a Large Proportion of Human Histocompatibility Leukocyte Antigen (HLA)-A2 Individuals. JEM 190: 705-716 [Abstract] [Full Text]
Suzuki, K., Sahara, H., Okada, Y., Yasoshima, T., Hirohashi, Y., Nabeta, Y., Hirai, I., Torigoe, T., Takahashi, S., Matsuura, A., Takahashi, N., Sasaki, A., Suzuki, M., Hamuro, J., Ikeda, H., Wada, Y., Hirata, K., Kikuchi, K., Sato, N. (1999). Identification of Natural Antigenic Peptides of a Human Gastric Signet Ring Cell Carcinoma Recognized by HLA-A31-Restricted Cytotoxic T Lymphocytes. J. Immunol. 163: 2783-2791 [Abstract] [Full Text]
Curry, B. J., Myers, K., Hersey, P. (1999). MART-1 Is Expressed Less Frequently on Circulating Melanoma Cells in Patients Who Develop Distant Compared With Locoregional Metastases. JCO 17: 2562-2562 [Abstract] [Full Text]
Yang, D., Nakao, M., Shichijo, S., Sasatomi, T., Takasu, H., Matsumoto, H., Mori, K., Hayashi, A., Yamana, H., Shirouzu, K., Itoh, K. (1999). Identification of a Gene Coding for a Protein Possessing Shared Tumor Epitopes Capable of Inducing HLA-A24-restricted Cytotoxic T Lymphocytes inCancer Patients. Cancer Res. 59: 4056-4063 [Abstract] [Full Text]
Borges, L., Miller, R. E., Jones, J., Ariail, K., Whitmore, J., Fanslow, W., Lynch, D. H. (1999). Synergistic Action of fms-Like Tyrosine Kinase 3 Ligand and CD40 Ligand in the Induction of Dendritic Cells and Generation of Antitumor Immunity In Vivo. J. Immunol. 163: 1289-1297 [Abstract] [Full Text]
Rongcun, Y., Salazar-Onfray, F., Charo, J., Malmberg, K.-J., Evrin, K., Maes, H., Kono, K., Hising, C., Petersson, M., Larsson, O., Lan, L., Appella, E., Sette, A., Celis3, E., Kiessling, R. (1999). Identification of New HER2/neu-Derived Peptide Epitopes That Can Elicit Specific CTL Against Autologous and Allogeneic Carcinomas and Melanomas. J. Immunol. 163: 1037-1044 [Abstract] [Full Text]